The selenoenzyme type I iodothyronine deiodinase: a new tumor suppressor in ovarian cancer,Molecular Oncology

当前位置： X-MOL 学术 › Mol. Oncol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

The selenoenzyme type I iodothyronine deiodinase: a new tumor suppressor in ovarian cancer
Molecular Oncology ( IF 6.6 ) Pub Date : 2024-03-02 , DOI: 10.1002/1878-0261.13612
Adi Alfandari _{1,

2,

3} , Dotan Moskovich _{1,

2,

3} , Avivit Weisz ₄ , Aviva Katzav ₄ , Debora Kidron _{3,

4} , Mario Beiner _{3,

5} , Dana Josephy ₅ , Aula Asali ₅ , Yael Hants ₅ , Yael Yagur ₆ , Omer Weitzner ₆ , Martin Ellis _{1,

3} , Gilad Itchaki _{1,

3} , Osnat Ashur‐Fabian _{1,

2,

3}

Affiliation

The selenoenzyme type I iodothyronine deiodinase (DIO1) catalyzes removal of iodine atoms from thyroid hormones. Although DIO1 action is reported to be disturbed in several malignancies, no work has been conducted in high‐grade serous ovarian carcinoma (HGSOC), the most lethal gynecologic cancer. We studied DIO1 expression in HGSOC patients [The Cancer Genome Atlas (TCGA) data and tumor tissues], human cell lines (ES‐2 and Kuramochi), normal Chinese hamster ovarian cells (CHO‐K1), and normal human fallopian tube cells (FT282 and FT109). To study its functional role, DIO1 was overexpressed, inhibited [by propylthiouracil (PTU)], or knocked down (KD), and cell count, proliferation, apoptosis, cell viability, and proteomics analysis were performed. Lower DIO1 levels were observed in HGSOC compared to normal cells and tissues. TCGA analyses confirmed that low DIO1 mRNA expression correlated with worse survival and therapy resistance in patients. Silencing or inhibiting the enzyme led to enhanced ovarian cancer proliferation, while an opposite effect was shown following DIO1 ectopic expression. Proteomics analysis in DIO1‐KD cells revealed global changes in proteins that facilitate tumor metabolism and progression. In conclusion, DIO1 expression and ovarian cancer progression are inversely correlated, highlighting a tumor suppressive role for this enzyme and its potential use as a biomarker in this disease.

更新日期：2024-03-02

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>